poisar

Stocks · News reference

Recent Report Shows That Rep. Rick Allen Sold Up to $50K Worth of Abbott Laboratories Stock

Aug 19, 2026, 3:00 PMBenzinga Insights

An official report on August 18, 2026 reveals Representative Rick Allen's recent sale of Abbott Laboratories (NYSE:ABT) stock, valued between $15,001 and $50,000. The transaction took place on July 14, 2026, as per

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ABTAMDINTU
Source
benzinga
Observed
Aug 19, 2026, 3:00 PM
Checked
Aug 19, 2026, 3:00 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 27, 2026, 5:00 PMDelveinsight

    Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsight

    The global blood-based biomarkers market is projected to grow from USD 8.5 billion in 2025 to USD 18.5 billion by 2034, driven by increasing demand for non-invasive diagnostics, rising chronic disease prevalence, and advances in genomics and liquid biopsy technologies. North America leads with 44% market share, while Asia-Pacific shows fastest growth. Key players include Roche, Abbott, Siemens Healthineers, and Thermo Fisher Scientific.

    Read original at globenewswire-inc
    RHHBYABTTMODGXLH
  2. Aug 27, 2026, 3:00 PMSns Insider

    Laboratory Informatics Market to Grow from USD 4.08 Billion in 2025 to USD 6.69 Billion by 2035, at a CAGR of 5.06% - SNS Insider

    The global laboratory informatics market is projected to grow at a CAGR of 5.06% from 2025 to 2035, driven by increased data processing demands, regulatory compliance requirements, and adoption of cloud-native solutions and AI-driven analytics. North America leads with 42.55% market share, while Asia-Pacific is the fastest-growing region. Services and LIMS products dominate, with cloud delivery and electronic lab notebooks showing the strongest growth rates.

    Read original at globenewswire-inc
    TMOAABTWATDHR
  4. Aug 26, 2026, 11:57 AMResearchandmarkets.Com

    Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic

    The global atrial fibrillation treatment devices market is expected to grow at a 13.1% CAGR from $9.6 billion in 2026 to $29 billion by 2035, driven by aging populations, rising AF prevalence affecting 50-60 million people worldwide, and increasing adoption of advanced ablation and left atrial appendage closure technologies. Pulsed field ablation is forecast to generate over 60% of market revenue by 2035, while North America will retain approximately 50% of global market share. Asia-Pacific is expected to register the fastest regional growth.

    Read original at globenewswire-inc
    ABTBSXATRCMDTJNJ
  5. Aug 27, 2026, 6:07 PMNa

    CBRS vs. AMD: Which Stock Leads the AI Infrastructure Boom?

    Cerebras Systems and Advanced Micro Devices are both benefiting from AI infrastructure growth. While AMD offers greater scale, profitability and diversification with Data Center revenues more than doubling, Cerebras appears to have an edge with faster growth expectations, $25.4B in remaining performance obligations, and strong partnerships with OpenAI and AWS. Cerebras expects core revenues to more than triple in 2027, though it remains unprofitable with customer concentration risks.

    Read original at zacks-investment-research
    CBRSAMD